Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A. - Wikidata - awgldk - TriplyDB

Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.

Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.

http://www.wikidata.org/entity/Q35213655

about

The Effect of Bone Marrow Mesenchymal Stem Cells on the Granulocytic Differentiation of HL-60 Cells.The cyclin-dependent kinase 4/6 inhibitor, abemaciclib, exerts dose-dependent cytostatic and cytocidal effects and induces autophagy in multiple myeloma cells.

P2860

Q38700425-53AC83D9-F7A4-4614-AB58-8D7522FFE624 Q50054859-88D0AF09-67AA-4600-8C41-86AD232AC82A

P2860

Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A.

http://www.wikidata.org/entity/Q35213655

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@ast

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@en

type

label

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@ast

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@en

prefLabel

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@ast

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@en

P1433

Q35213655-9F558C25-54F8-4B85-AFC8-5CF9C0734540

P1476

Q35213655-E60EC3E7-7BED-4826-B4A4-580C5F7CAD8D

P2093

Q35213655-147F3E3C-409D-4048-A249-26361A664EF7

Q35213655-2B53CA32-DA2C-407E-B87D-56BB35D6E19F

Q35213655-4ACBB8A9-20B4-48C8-B812-A2E6AEAA9554

Q35213655-C5BD3208-027D-4311-B78E-06361EA2C6FF

P2860

Q35213655-018E23C4-1F12-4122-A4D9-9887B378F121

Q35213655-040AC7EA-D4F7-46B4-9CF8-8DDF73CC79FD

Q35213655-0BFECD6B-F926-40B3-9C30-A8C9B198B310

Q35213655-0D59D891-7BC1-43A8-8B7A-17FBE3E13AFF

Q35213655-0E806237-994B-4A01-A8A8-F312C69271CA

Q35213655-127D9ED1-8227-48D7-8FEC-FF7691CC7A66

Q35213655-17C1246A-994C-43DF-91C6-6E3ED727DA94

Q35213655-28CF1254-F714-4755-8F6F-4F46B712C1A9

Q35213655-2F67A1FF-476F-44C1-94A2-E6B7DB8BB3FF

Q35213655-32E1AB7B-8883-4133-931A-3CE55810B2C8

P2888

Q35213655-007D307A-7E2D-489D-86F4-F04322D32115

P304

Q35213655-DD3AD71A-B764-47AC-8504-2CC22574D45F

P31

Q35213655-B39B5735-596A-44AC-ADD6-A3F67B590336

P356

Q35213655-00175A31-D98C-45DC-9BB8-4DFFA644BCEB

P478

Q35213655-7C5F99A1-402C-4ABE-9461-C533866131CE

P577

Q35213655-FBB85D2E-EBAA-4EC4-A94F-8D8231B472DD

P5875

Q35213655-039AC9FB-FA66-4A60-88AC-968C2276B732

P6179

Q35213655-578647ED-3FEF-4E91-99E5-657A9DA335FE

P698

Q35213655-0DFBEF8D-331E-4A4B-BAA2-D34EF970195D

P932

Q35213655-5B559C8A-EB7D-4B71-BB01-94462961F5A5

P356

S12935-015-0176-2

P1433

Cancer Cell International

P1476

Granulocyte colony-stimulating ...... ytic leukemia cell line HT93A.

@en

P2093

Masami Takei

http://www.w3.org/2001/XMLSchema#string

Noriyoshi Iriyama

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Hatta

http://www.w3.org/2001/XMLSchema#string

Yoshihito Uchino

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

Signaling by STATs

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

G-CSF and its receptor in myeloid malignancy

Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis.

Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.

Role of Jak kinases and STATs in cytokine signal transduction.

P2888

s12935-015-0176-2

P304

30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-015-0176-2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274089664

http://www.w3.org/2001/XMLSchema#string

P6179

1005450968

http://www.w3.org/2001/XMLSchema#string

P698

25805962

http://www.w3.org/2001/XMLSchema#string

P932

4372317

http://www.w3.org/2001/XMLSchema#string